This is a non-core endpoint: only basic statistics are computed.
Multiple myeloma
C3_MULT_MYELOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1903 |
4. Check minimum number of eventsNone |
1903 |
5. Include endpointsNone |
1903 |
6. Filter based on genotype QC (FinnGen only) |
1082 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Multiple myeloma
based on the number of shared cases.
Similar with more cases:
- Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)
- Multiple myeloma, including Hilmo
- Liquid cancers
- Liquid cancers, including Hilmo
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1082 | 466 | 616 |
| Unadjusted period prevalence (%) | 0.23 | 0.17 | 0.28 |
| Median age at first event (years) | 71.32 | 70.62 | 71.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1123
- Matched controls
- 11230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WW500
NOMESCO Finland
Blood transfusion
28.6
316.2
222
96
329
Kela drug reimbursment
Lenalidomide
+∞
307.7
484
*
L03AA02
ATC
filgrastim; parenteral
5380.8
307.7
379
*
H02AB02
ATC
dexamethasone; systemic
434.7
307.7
794
62
M04AA01
ATC
allopurinol; systemic
10.6
307.7
621
1176
A04AA01
ATC
ondansetron; systemic, rectal
59.4
307.7
448
124
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4504.6
307.7
930
12
B03XA02
ATC
darbepoetin alfa; parenteral
39.3
307.7
217
68
C90.0
ICD-10 Finland
Multiple myeloma
+∞
307.7
1075
*
L04AX04
ATC
lenalidomide; oral
+∞
307.7
613
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
307.7
1067
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
45.6
307.7
206
55
ZX112
NOMESCO Finland
Subcutaneous
109.8
307.7
228
26
153
Kela drug reimbursment
Lenalidomid
+∞
307.7
658
*
AA1AA
NOMESCO Finland
Head X-ray examination
84.4
307.7
207
30
J05AB01
ATC
aciclovir; systemic
9.5
307.7
656
1453
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
16.4
307.7
327
274
XW000
NOMESCO Finland
Bone marrow biopsy
83.3
307.7
561
133
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
28.8
292.8
204
86
N02AA05
ATC
oxycodone; systemic
8.5
286.3
576
1244
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
19.4
255.9
212
133
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
753.8
251.7
239
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.7
239.6
801
2742
ZX120
NOMESCO Finland
Intravenous
10.4
239.2
310
396
L01AA03
ATC
melphalan; systemic
+∞
236.0
218
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2492.9
231.4
216
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1272.7
220.5
208
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
69.9
217.8
119
19
WW300
NOMESCO Finland
Transfer of autologic stem cells
2304.9
216.9
203
*
JN4AD
NOMESCO Finland
Body CT examination
9.5
208.5
287
392
393
Kela drug reimbursment
Pomalidomide
+∞
205.7
191
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
1147.1
201.5
191
*
B03XA01
ATC
erythropoietin; parenteral
53.3
199.9
115
24
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.3
196.6
248
302
L04AX06
ATC
pomalidomide; oral
+∞
195.7
182
*
1507
Kela drug reimbursment
Pomalidomide
+∞
193.5
180
*
Z51.5
ICD-10 Finland
Palliative care
9.3
178.7
243
324
ZX108
NOMESCO Finland
Inhalation
62.4
174.1
97
17
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
170.2
159
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.5
168.8
168
144
212
Kela drug reimbursment
Gout
14.3
157.8
151
121
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
1728.2
156.0
148
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
11.4
155.4
174
178
R50.9
ICD-10 Finland
Fever, unspecified
5.6
146.4
365
896
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.7
144.8
347
822
J05AB11
ATC
valaciclovir; oral
5.5
142.5
359
887
A03FA01
ATC
metoclopramide; systemic, rectal
5.8
137.8
313
704
M05BA02
ATC
clodronic acid; systemic
1467.4
136.4
130
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1416.4
132.0
126
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
50.9
131.2
76
16
XX3DW
NOMESCO Finland
Time consuming IT work
8.9
130.9
178
234
L01AA01
ATC
cyclophosphamide; systemic
66.8
125.4
69
11
B01AB05
ATC
enoxaparin; parenteral
4.1
117.2
565
2244
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
1204.5
113.7
109
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
1204.5
113.7
109
*
M05BX04
ATC
denosumab; parenteral
6.4
108.1
200
366
WZC00
NOMESCO Finland
Treatment plan or consultation
3.9
107.6
494
1875
WW200
NOMESCO Finland
Immunization
12.2
107.1
111
100
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.9
102.6
271
681
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
39.2
102.3
63
17
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
192.8
102.2
105
6
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
98.4
93
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.9
97.0
252
623
WW409
NOMESCO Finland
Other aferesis
+∞
95.2
90
*
B01AB10
ATC
tinzaparin; parenteral
5.3
93.3
213
471
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
336.3
92.3
92
*
1XX32, ,
NOMESCO Finland
+∞
92.0
87
*
398
Kela drug reimbursment
Ixazomib
+∞
92.0
87
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
92.0
87
*
B74
ICPC
Malignant neoplasm blood other
928.8
89.0
86
*
WF004
NOMESCO Finland
Palliative radiotherapy
905.4
86.8
84
*
1505
Kela drug reimbursment
Ixazomib
+∞
86.6
82
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
27.0
85.4
59
23
J01MA12
ATC
levofloxacin; systemic
3.7
85.3
369
1314
5BA08, ,
NOMESCO Finland
29.4
83.5
56
20
L04AX02
ATC
thalidomide; oral
858.9
82.6
80
*
E83.50
ICD-10 Finland
Hypercalcemia
14.5
81.6
75
55
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
80.2
76
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
79.1
75
*
JN4BD
NOMESCO Finland
Extensive body CT
6.3
78.6
142
251
TK800
NOMESCO Finland
Hemodialysis
10.9
77.6
86
85
C61
ICD-10 Finland
Malignant neoplasm of prostate
279.3
77.5
78
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.8
77.0
292
945
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
75.9
72
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
74.8
546
2630
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
267.6
74.3
75
*
GA5AA
NOMESCO Finland
Rib X-ray examination
39.0
72.9
45
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
72.8
738
4247
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.3
71.9
99
130
WW402
NOMESCO Finland
Leucoferesis
+∞
69.5
66
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.4
68.6
148
308
3060, ,
Kela drug reimbursment
+∞
68.4
65
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
68.4
65
*
1534, ,
Kela drug reimbursment
+∞
67.4
64
*
L01FC01
ATC
daratumumab; parenteral
+∞
67.4
64
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.4
64.5
113
193
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
7.2
64.1
99
148
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
63.1
60
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
62.1
59
*
L03AA13
ATC
pegfilgrastim; parenteral
330.7
62.0
62
*
A04AA02
ATC
granisetron; systemic, transdermal
211.1
58.6
60
*
J01MA14
ATC
moxifloxacin; systemic
3.9
57.0
191
560
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
56.7
54
*
A02BC02
ATC
pantoprazole; systemic
3.1
54.0
876
6036
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
53.6
51
*
A06AH03
ATC
naloxegol; oral
21.8
53.4
40
19
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.2
52.6
94
163
GD1AD
NOMESCO Finland
Thorax CT examination
4.6
52.0
134
322
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
51.6
148
386
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
50.8
217
743
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
50.8
330
1437
A79
ICPC
Malignancy NOS
267.0
50.5
51
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
50.4
48
*
L01XG03
ATC
ixazomib; oral
+∞
50.4
48
*
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
498.6
48.7
48
*
C03CA01
ATC
furosemide; systemic
2.5
48.3
608
3621
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
14.9
47.8
43
30
NF3AA
NOMESCO Finland
Femur X-ray examination
6.5
46.9
79
129
D70.89
ICD-10 Finland
Neutropenic splenomegaly
19.1
46.7
37
20
ZX090
NOMESCO Finland
Other technic of radiotherapy
104.6
46.2
50
5
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
46.0
331
1509
NB6AA
NOMESCO Finland
Humerus X-ray examination
6.3
45.5
79
133
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
87.2
45.2
50
6
116
Kela drug reimbursment
Prostate cancer
+∞
45.1
43
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
100.2
44.1
48
5
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
+∞
44.0
42
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
10.9
42.2
46
44
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.2
42.2
120
310
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
41.9
40
*
H02AB09
ATC
hydrocortisone; systemic
7.9
41.5
58
77
127
Kela drug reimbursment
Transplant complication
14.0
40.9
38
28
WVA20
NOMESCO Finland
Medicine administration
6.4
40.9
70
116
L01XX50
ATC
[U] ixazomib
+∞
40.9
39
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
411.7
40.4
40
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
411.7
40.4
40
*
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
12.5
40.3
40
33
130
Kela drug reimbursment
Malignant tumour
+∞
39.8
38
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
39.1
135
400
WZC30
NOMESCO Finland
Teaching
2.9
38.0
205
796
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.3
37.8
488
2848
A06AD11
ATC
lactulose; oral
2.5
37.8
292
1361
115
Kela drug reimbursment
Breast cancer
+∞
37.7
36
*
N17.8
ICD-10 Finland
Other acute renal failure
8.5
37.4
49
60
PJA12
NOMESCO Finland
Sentinel node biopsy
379.4
37.2
37
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
36.7
35
*
WF002
NOMESCO Finland
Radical radiotherapy
62.2
36.4
42
7
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.0
35.8
80
170
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.3
35.4
53
76
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
347.3
34.1
34
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
33.5
32
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
33.5
32
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
11.3
33.0
35
32
H02AB06
ATC
prednisolone; systemic
2.1
32.6
601
3965
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.7
32.4
77
172
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
31.9
90
230
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.5
31.9
53
85
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
9.8
31.6
37
39
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
31.2
186
757
JN4CD
NOMESCO Finland
Very extensive body CT
7.6
30.7
44
60
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
30.3
29
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
30.3
29
*
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
+∞
30.3
29
*
A05AA02
ATC
ursodeoxycholic acid; oral
9.5
30.2
36
39
N02AX02
ATC
tramadol; systemic, rectal
2.1
30.1
536
3458
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
29.3
28
*
N03AX16
ATC
[U] pregabalin
2.2
29.0
308
1627
A11CC03
ATC
alfacalcidol; systemic
5.4
28.9
58
112
EBA10
NOMESCO Finland
Operative extraction of tooth
3.1
28.2
130
459
E85.9
ICD-10 Finland
Amyloidosis, unspecified
40.1
28.2
35
9
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
148.7
27.8
29
*
1CX01, ,
NOMESCO Finland
+∞
27.2
26
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.4
26.9
70
168
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
26.8
556
3736
L02AE02
ATC
leuprorelin; implant, parenteral
95.7
25.8
28
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
45.4
25.6
31
7
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
51.3
25.3
30
6
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.5
25.3
63
146
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.7
25.2
83
237
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
59.5
25.1
29
5
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
25.1
24
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
25.1
24
*
E85.89
ICD-10 Finland
Other amyloidosis
133.0
24.7
26
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
24.6
185
837
HA1AA
NOMESCO Finland
X-ray mammography
4.7
24.0
57
127
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
24.0
23
*
N05CF01
ATC
zopiclone; oral
1.9
24.0
431
2729
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
23.9
119
438
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
127.7
23.7
25
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
23.0
22
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.9
22.2
389
2430
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
22.1
172
789
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
21.9
21
*
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
+∞
21.9
21
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
21.9
21
*
5BA03, ,
NOMESCO Finland
+∞
21.9
21
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
63.8
21.9
25
*
L02BG04
ATC
letrozole; oral
81.8
21.7
24
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.4
21.7
43
82
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.3
21.3
83
264
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.0
21.2
46
95
Z3231
NOMESCO Finland
Registered nurse
2.0
21.1
313
1843
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
21.0
59
150
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
20.9
20
*
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
20.9
20
*
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
20.9
20
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.5
20.6
142
615
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.3
20.3
34
55
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.5
20.0
49
112
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.4
20.0
29
40
Z51.0
ICD-10 Finland
Radiotherapy session
203.4
19.6
20
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
25.1
19.6
27
11
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
19.4
322
1960
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
19.3
349
2184
N19
ICD-10 Finland
Unspecified kidney failure
3.0
19.2
87
303
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
35.0
18.9
24
7
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.2
18.9
39
77
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
18.8
18
*
306
Kela drug reimbursment
Erythropoietin and darbepoetin
71.1
18.8
21
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
18.7
406
2681
ECB20
NOMESCO Finland
Oral alveoplasty
7.8
18.7
26
34
WZC15, ,
NOMESCO Finland
101.8
18.6
20
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
39.1
18.6
23
6
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
193.1
18.6
19
*
NB4AA
NOMESCO Finland
Scapula X-ray examination
18.4
17.8
27
15
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
17.8
17
*
Y77
ICPC
Malignant neoplasm prostate
96.6
17.6
19
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
17.5
152
728
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
29.3
17.5
23
8
ZXD05
NOMESCO Finland
Urgent procedure
1.8
17.4
344
2200
SPAT1255
SPAT
Intravenous administration of medicine
2.6
17.0
103
419
A28
ICPC
Limited function/disability NOS
1.8
16.8
307
1913
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.7
16
*
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
+∞
16.7
16
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
16.7
16
*
A07AA02
ATC
nystatin; oral
2.7
16.6
91
351
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
6.8
16.6
26
39
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
172.5
16.5
17
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
13.6
16.5
28
21
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.4
16.0
40
93
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.3
15.9
32
62
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.9
15.8
20
6
L02BB03
ATC
bicalutamide; oral
+∞
15.7
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
15.7
15
*
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
15.7
15
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
15.3
60
192
NA2AD
NOMESCO Finland
Thoracic spine CT examination
13.3
15.2
26
20
SPAT1088
SPAT
Blood transfusion
18.0
15.2
23
13
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.3
15.1
39
93
WF099
NOMESCO Finland
Other radiotherapy
32.2
14.8
19
6
C50.99
ICD-10 Finland
Breast, unspecified
+∞
14.6
14
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
14.6
14
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
81.2
14.6
16
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.0
14.6
31
63
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
151.9
14.5
15
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
151.9
14.5
15
*
3XA02, ,
NOMESCO Finland
151.9
14.5
15
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
36.5
14.5
18
5
R4190
NOMESCO Finland
Nutritional therapy
4.6
14.1
33
73
HAB40
NOMESCO Finland
Wedge excision of mammary gland
24.1
13.8
19
8
A40.8
ICD-10 Finland
Other streptococcal sepsis
5.0
13.6
29
59
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
76.1
13.6
15
*
1AA01, ,
NOMESCO Finland
76.1
13.6
15
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
13.6
13
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
13.6
13
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.5
13.5
47
139
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
141.7
13.5
14
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
13.3
188
1073
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
3.1
13.3
55
182
C10AA07
ATC
rosuvastatin; oral
0.5
13.2
172
2861
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
13.2
81
331
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.6
13.2
44
127
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
15.3
13.1
21
14
A07AA09
ATC
vancomycin; oral
4.9
12.9
28
58
ZX100
NOMESCO Finland
Oral
5.4
12.8
25
47
L57.0
ICD-10 Finland
Actinic keratosis
2.1
12.8
121
598
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
12.7
196
1151
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
4.7
12.6
29
63
HAC20
NOMESCO Finland
Total mastectomy
70.7
12.6
14
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
12.5
12
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
12.5
12
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
12.5
12
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
12.5
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
12.5
12
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
12.4
259
1659
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
12.4
34
85
ZXE00
NOMESCO Finland
One hour or less
1.6
12.4
383
2719
H02AB07
ATC
prednisone; oral
1.9
12.3
168
946
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
38.0
12.2
15
*
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
12.6
12.1
21
17
B02.9
ICD-10 Finland
Zoster without complication
2.3
12.1
98
455
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.8
12.0
25
29
ZYC01
NOMESCO Finland
Remote contact by phone
2.6
12.0
71
285
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
11.9
130
678
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.7
11.7
62
235
N02BF02
ATC
pregabalin; oral
2.4
11.7
82
357
ZZR00
NOMESCO Finland
Flap of skin
12.7
11.6
20
16
J02AC03
ATC
voriconazole; systemic
65.6
11.6
13
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
19.2
11.6
17
9
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
19.2
11.6
17
9
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.5
11.6
40
118
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
11.5
61
232
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
11.5
11
*
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
+∞
11.5
11
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
11.5
11
*
WD335, ,
NOMESCO Finland
+∞
11.5
11
*
A12AA04
ATC
calcium carbonate; oral
4.6
11.5
27
60
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
121.2
11.4
12
*
L02BA01
ATC
tamoxifen; oral
121.2
11.4
12
*
J01CA04
ATC
amoxicillin; systemic
1.6
11.3
819
7015
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.9
11.3
157
889
D64.8
ICD-10 Finland
Other specified anaemias
3.8
11.2
34
92
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
20.3
11.1
16
8
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.7
10.9
61
238
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
15.7
10.8
17
11
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
15.7
10.8
17
11
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
8.4
10.8
23
28
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
5.2
10.8
22
43
R06AE07
ATC
cetirizine; oral
1.6
10.8
395
2899
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.5
10.8
37
109
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
10.6
74
321
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
60.6
10.6
12
*
L04AD01
ATC
ciclosporin; systemic
5.1
10.5
22
44
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
111.0
10.4
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
111.0
10.4
11
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
10.4
10
*
L03AA04, ,
ATC
+∞
10.4
10
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
10.4
10
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
10.4
10
*
YX9AW, ,
NOMESCO Finland
+∞
10.4
10
*
9731/3-C42.1
ICD-O-3
Plasmacytoma, NOS, of bone marrow
+∞
10.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.4
10
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
10.4
10
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
10.4
10
*
JN4BG
NOMESCO Finland
Body MRI with high intensity magnet
+∞
10.4
10
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
10.4
10
*
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
8.3
10.3
22
27
6BA02, ,
NOMESCO Finland
32.8
10.3
13
*
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
9.7
10.3
20
21
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.4
10.2
37
113
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.0
10.2
45
155
ZX114
NOMESCO Finland
Intramuscular
5.3
10.1
20
38
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.7
10.0
53
202
R4110
NOMESCO Finland
Physiotherapy
1.6
10.0
280
1926
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.2
9.9
26
63
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
9.7
129
718
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.1
9.7
40
132
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.7
9.7
52
199
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
9.7
63
265
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
9.7
44
154
N02BE01
ATC
paracetamol; systemic, rectal
1.7
9.6
950
8559
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.5
9.6
23
52
OAB42, ,
SPAT
0.3
9.5
30
885
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
17.7
9.4
14
8
N08.2*D89.82
ICD-10 Finland
Nepropathy caused by deposition of the light chain of the immunoglobulins
+∞
9.4
9
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
9.4
9
*
L02BG03
ATC
anastrozole; oral
+∞
9.4
9
*
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
+∞
9.4
9
*
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
B73
ICPC
Leukaemia
+∞
9.4
9
*
B99
ICPC
Blood/lymph/spleen disease other
21.9
9.4
13
6
R80
ICD-10 Finland
Isolated proteinuria
7.0
9.3
22
32
ZX112, ,
SPAT
8.8
9.3
19
22
A10AC01
ATC
insulin (human); parenteral
2.0
9.2
110
592
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
9.2
87
430
C10AX09
ATC
ezetimibe; oral
0.5
9.1
74
1460
WPA13
NOMESCO Finland
Palliative consultation
15.7
9.0
14
9
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
8.9
131
753
J01DB01
ATC
cefalexin; oral
1.5
8.9
820
7173
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
24.2
8.9
12
5
S42.3
ICD-10 Finland
Fracture of shaft of humerus
4.0
8.9
25
64
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
8.8
38
129
JN6AD
NOMESCO Finland
CT of torso and neck
8.7
8.8
18
21
X76
ICPC
Malignant neoplasm breast female
50.4
8.7
10
*
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.4
8.7
31
94
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.4
8.7
31
94
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
7.7
8.7
19
25
UJF32
NOMESCO Finland
Coloscopy
1.6
8.7
276
1947
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
8.6
75
358
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
27.7
8.5
11
*
W0X00
NOMESCO Finland
Estimation of continuous need for medical therapy
27.7
8.5
11
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
27.7
8.5
11
*
N06DX01
ATC
memantine; oral
0.4
8.5
40
977
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.9
8.4
24
62
XX1AD
NOMESCO Finland
Other CT-examination
90.7
8.4
9
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
3.8
8.4
25
67
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
8.4
326
2399
1XX45, ,
NOMESCO Finland
+∞
8.3
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
8.3
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
8.3
8
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
8.3
8
*
NAR00
NOMESCO Finland
Complete excision of tumour of bone or cartilage of spine, unspecified
+∞
8.3
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.3
8
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
8.3
8
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
8.3
8
*
WX704
NOMESCO Finland
Intubation
2.1
8.3
78
384
C10AC01
ATC
colestyramine; oral
3.2
8.3
32
102
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
8.2
407
3139
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
8.2
105
1793
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
8.2
74
359
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.5
8.2
264
1864
A41.8
ICD-10 Finland
Other specified sepsis
3.1
8.2
33
108
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
8.2
8.1
17
21
J12.2
ICD-10 Finland
Parainfluenza virus pneumonia
33.6
8.1
10
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
17.3
8.1
12
7
Z2221
NOMESCO Finland
Medical doctor
1.6
8.0
245
1708
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.2
8.0
21
51
NC2AA
NOMESCO Finland
Forearm X-ray examination
4.2
8.0
21
51
TQW99
NOMESCO Finland
Other minor procedure on skin
2.5
8.0
51
213
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
8.0
87
453
N18.0
ICD-10 Finland
End-stage renal disease
4.3
8.0
20
47
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.4
8.0
56
245
A02BC01
ATC
omeprazole; systemic
1.5
7.8
301
2204
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.5
7.8
49
204
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
15.1
7.7
12
8
B01.9
ICD-10 Finland
Varicella without complication
15.1
7.7
12
8
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
45.3
7.7
9
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
45.3
7.7
9
*
WW200, ,
SPAT
0.6
7.7
173
2551
NB3AA
NOMESCO Finland
Clavicle X-ray examination
3.8
7.7
23
62
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
18.5
7.6
11
6
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.1
7.6
16
20
WX882
NOMESCO Finland
High dependency care
2.8
7.6
37
135
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
7.6
106
600
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.9
7.6
13
11
L04AA06
ATC
mycophenolic acid; systemic
3.9
7.5
21
54
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
80.6
7.4
8
*
B01AB04
ATC
dalteparin; parenteral
2.4
7.4
51
221
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
13.5
7.4
12
9
B82
ICPC
Anaemia other/unspecified
2.5
7.3
44
179
WX402
NOMESCO Finland
General anaesthesia
1.6
7.3
163
1053
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
6.9
7.3
17
25
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
7.3
7
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
GA5DA
NOMESCO Finland
Bilateral rib X-ray exmaination
+∞
7.3
7
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
7.3
7
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
7.3
7
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
7.3
46
192
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
6.3
7.3
18
29
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.5
7.2
44
180
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
7.2
57
262
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.8
7.2
19
33
TGC00
NOMESCO Finland
Bronchial lavation
2.8
7.2
34
122
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.7
7.2
22
60
WX892
NOMESCO Finland
Monitored bed care
1.9
7.2
91
499
XQ848
NOMESCO Finland
Dermatological photography
3.0
7.2
31
106
D69.5
ICD-10 Finland
Secondary thrombocytopenia
30.2
7.2
9
*
WPB10
NOMESCO Finland
Making a convalescent care decision
20.2
7.1
10
5
K10.25
ICD-10 Finland
Sequences of jawbones
12.1
7.1
12
10
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.8
7.1
35
129
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
7.0
7.0
16
23
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
7.0
230
1626
S72.3
ICD-10 Finland
Fracture of shaft of femur
4.4
7.0
17
39
ZXC50
NOMESCO Finland
Cryotherapy
2.9
6.9
31
108
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
6.9
79
420
E83.51
ICD-10 Finland
Hypocalcemia
6.7
6.8
16
24
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
11.0
6.8
12
11
ZY010
NOMESCO Finland
Hospital outpatient
2.6
6.8
37
144
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
6.7
107
631
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
22.7
6.7
9
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.6
180
1219
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
5.5
6.6
18
33
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
5.5
6.6
18
33
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
6.6
235
1687
R06.0
ICD-10 Finland
Dyspnoea
1.4
6.6
322
2458
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
6.6
17
41
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
6.5
43
183
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.9
6.5
15
22
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.5
629
5387
A10AB05
ATC
insulin aspart; parenteral
1.8
6.5
93
532
V03AE01
ATC
polystyrene sulfonate; oral
3.4
6.4
22
65
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
70.2
6.4
7
*
WX720
NOMESCO Finland
Own respiration
2.1
6.3
58
284
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
20399
ICD-8 Finland
Multiple myeloma
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
L02AE04
ATC
triptorelin; parenteral
+∞
6.3
6
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
6.3
6
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.3
6
*
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
3AA13, ,
NOMESCO Finland
+∞
6.3
6
*
E85.8
ICD-10 Finland
Other amyloidosis
+∞
6.3
6
*
ZXY12
NOMESCO Finland
Trainee nurse, supervised
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
6.3
39
162
TPX15
NOMESCO Finland
Removal of vascular injection port
26.8
6.2
8
*
H26.3
ICD-10 Finland
Drug-induced cataract
7.1
6.2
14
20
H02AB04
ATC
methylprednisolone; systemic
1.6
6.2
153
1012
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
5.1
6.2
18
36
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.4
6.2
21
62
KCD02
NOMESCO Finland
Transurethral resection of bladder
7.7
6.1
13
17
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
8.7
6.1
12
14
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.6
6.1
19
53
M54.5
ICD-10 Finland
Low back pain
1.4
6.0
337
2627
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
6.7
6.0
14
21
J01FF01
ATC
clindamycin; systemic
1.4
6.0
257
1910
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
610
464
27.59
307.65
19.6
1.5
7.01
7.63
g/l
9.97
601
403
654
1296
10.69
307.65
4.7
1.9
1.66
1.76
%
1.77
629
1130
565
397
27.63
307.65
19.3
1.5
7.16
0.48
g/l
36.68
492
333
357
320
15.89
307.65
23.1
1.4
0.00
0.00
g/l
0.65
303
286
660
1475
9.43
307.65
7.9
1.3
3.31
2.79
g/l
0.96
586
824
805
379
72.48
307.65
23.8
1.5
228.68
46.27
mg/l
1.98
748
322
486
97
87.57
307.65
1.8
1.2
—
—
—
0
0
721
571
33.48
307.65
11.7
2.3
12.97
11.04
g/l
3.41
687
522
561
430
25.07
307.65
20.4
1.5
2.54
3.02
g/l
14.64
552
370
580
1009
10.82
307.65
4.0
2.0
59.09
66.91
e9/l
5.55
454
757
610
464
27.59
307.65
19.6
1.5
4.22
4.22
g/l
0.00
600
404
503
108
83.55
307.65
4.6
1.9
0.77
1.98
g/24h
1.38
371
61
274
119
30.13
307.65
6.4
4.6
236.63
359.22
iu/ml
0.37
64
18
806
378
73.00
307.65
23.8
1.5
133.29
35.08
mg/l
4.65
748
321
749
993
20.65
307.65
13.5
2.0
223.75
235.11
u/l
2.51
735
917
387
328
17.48
307.65
21.9
1.4
0.26
0.00
g/l
3.42
345
299
619
454
29.15
307.65
5.5
1.3
0.50
1.16
g/l
11.17
506
414
782
334
74.81
307.65
21.5
1.5
35.26
1.43
ratio
2.41
618
201
822
892
31.65
307.65
24.7
1.6
67.10
66.77
g/l
0.35
807
800
610
464
27.59
307.65
19.6
1.5
3.49
3.74
g/l
0.88
601
404
486
412
20.03
307.65
21.2
1.5
11.08
10.55
g/l
0.51
461
351
309
303
13.69
290.48
25.9
1.4
0.00
0.00
g/l
-0.00
303
285
594
1324
8.40
286.55
11.5
4.9
1.10
1.03
mmol/l
4.19
577
1216
251
211
15.03
258.48
2.7
1.4
—
—
—
0
0
243
210
14.49
245.65
2.5
1.4
—
—
—
0
0
180
89
23.89
241.65
2.2
2.0
241.29
262.43
u/ml
—
7
14
735
2500
6.62
215.02
10.9
2.5
328.75
361.40
umol/l
11.41
714
2117
200
155
15.48
214.70
1.4
1.1
75.63
21.55
u/l
9.40
190
134
206
6
424.78
211.63
1.6
1.0
—
—
—
0
0
174
111
18.37
207.15
4.5
2.6
1.77
1.68
%
0.05
164
90
226
227
12.21
206.14
1.5
1.5
—
—
—
0
0
178
137
15.25
191.25
2.9
1.4
—
—
—
0
0
529
1484
5.85
187.71
7.3
2.3
0.80
0.83
mmol/l
6.48
518
1366
183
7
311.82
184.85
1.2
1.1
—
—
—
0
0
139
76
20.73
177.54
3.1
1.4
—
—
—
0
0
348
707
6.68
173.91
2.5
1.6
—
—
—
0
0
140
83
19.13
172.11
3.1
1.3
—
—
—
0
0
114
41
30.83
171.19
8.4
1.2
41.10
39.11
g/l
1.19
114
41
286
503
7.29
164.10
2.3
1.6
1.45
1.54
g/l
0.69
266
433
101
30
36.89
160.63
1.9
2.1
33.44
47.81
%
3.00
36
17
126
86
16.38
143.80
4.4
2.8
57.62
57.73
%
0.01
116
67
539
1864
4.64
140.55
3.8
1.9
—
—
—
0
0
86
24
38.72
138.88
3.6
1.1
—
—
—
0
0
85
24
38.23
136.81
3.5
1.1
—
—
—
0
0
85
24
38.23
136.81
3.5
1.1
—
—
—
0
0
113
69
18.10
136.41
3.1
1.2
—
—
—
0
0
113
69
18.10
136.41
3.1
1.2
—
—
—
0
0
113
69
18.10
136.41
3.1
1.2
—
—
—
0
0
92
35
28.54
135.13
3.4
1.1
—
—
—
0
0
92
35
28.54
135.13
3.4
1.1
—
—
—
0
0
92
35
28.54
135.13
3.4
1.1
—
—
—
0
0
92
35
28.54
135.13
3.4
1.1
—
—
—
0
0
130
105
13.87
134.77
1.5
1.2
146.78
161.04
au/ml
0.43
36
38
162
186
10.01
132.51
1.3
1.3
—
—
—
0
0
117
87
14.90
127.14
4.2
2.3
—
—
—
0
0
815
4021
4.74
126.95
19.6
5.4
54.87
58.78
%
15.36
800
3787
95
49
21.09
123.83
3.6
2.2
9.85
78.15
iu/ml
—
21
6
346
936
4.90
121.35
10.4
5.8
13.16
11.42
mmol/l
2.71
331
887
825
4219
4.60
119.37
27.6
3.9
34.08
35.05
g/l
5.01
802
3893
457
1568
4.23
116.62
3.3
1.9
28.51
29.79
s
4.03
439
1522
69
17
43.18
114.75
2.1
1.1
—
—
—
0
0
98
67
15.93
111.30
1.2
1.0
—
—
—
0
0
838
4465
4.45
111.11
21.2
5.4
1.48
1.79
e9/l
19.60
781
3848
845
4536
4.49
110.68
21.6
5.4
0.15
0.20
e9/l
9.98
781
3867
859
4697
4.53
108.79
51.1
6.0
3.04
4.44
e9/l
84.29
798
3987
112
7
177.47
108.42
4.3
1.1
—
—
—
0
0
198
358
6.50
108.31
1.8
1.2
—
—
—
0
0
431
1485
4.09
108.08
3.5
2.6
24.47
21.84
%
3.73
420
1363
110
6
202.96
107.49
10.2
1.2
—
—
—
0
0
447
1607
3.96
104.98
3.5
2.6
2.08
2.25
g/l
8.12
429
1473
77
38
21.68
102.03
2.9
1.5
—
—
—
0
0
412
1437
3.95
100.44
2.9
1.8
—
—
—
0
0
831
4589
4.12
99.97
20.6
3.8
10.06
12.33
umol/l
11.94
822
4308
456
1729
3.76
97.81
3.5
2.6
12.93
12.16
umol/l
1.58
440
1585
868
4994
4.25
96.92
46.4
6.1
1.21
1.21
mmol/l
0.18
809
4284
135
189
7.98
93.31
1.7
1.3
—
—
—
0
0
805
4475
3.82
92.93
35.4
5.7
1.21
1.21
mmol/l
1.19
787
4036
75
43
18.62
92.84
1.3
1.3
—
—
—
0
0
75
43
18.62
92.84
1.3
1.3
—
—
—
0
0
368
1328
3.63
83.10
3.0
1.9
—
—
—
0
0
84
75
12.02
81.19
1.3
1.2
—
—
—
0
0
56
22
26.74
80.82
3.6
1.9
1.28
0.93
%
0.65
56
22
115
161
7.84
79.22
1.5
1.3
—
—
—
0
0
95
107
9.61
78.03
1.7
1.4
—
—
—
0
0
90
99
9.80
75.20
1.7
1.5
—
—
—
0
0
94
110
9.23
74.94
1.6
1.2
178.79
260.37
u/ml
1.21
53
54
66
46
15.18
73.81
2.1
5.5
—
37.50
—
0
10
61
39
16.48
71.36
2.5
1.3
—
—
—
0
0
61
39
16.48
71.36
2.5
1.3
—
—
—
0
0
68
57
12.63
68.26
2.3
1.3
—
—
—
0
0
68
57
12.63
68.26
2.3
1.3
—
—
—
0
0
108
169
6.96
67.09
1.9
1.3
—
—
—
0
0
688
3923
2.95
66.80
8.0
2.4
—
—
estimate
—
0
0
129
247
5.77
65.45
2.1
1.3
—
—
—
0
0
272
928
3.55
65.30
7.0
2.2
5.54
8.35
umol/l
3.41
248
815
257
849
3.63
64.79
3.8
3.7
93.06
93.58
ng/l
0.03
225
718
595
3193
2.84
63.92
9.4
2.1
2.32
2.35
mmol/l
6.41
573
2765
67
5
142.34
63.61
1.2
1.2
—
—
—
0
0
174
449
4.40
61.98
2.4
1.7
2.88
1.89
ug/l
0.51
158
392
94
140
7.24
61.03
1.7
1.3
—
—
—
0
0
447
2105
2.87
61.02
7.8
2.1
—
—
—
0
0
47
24
20.40
61.01
1.9
3.0
—
—
—
0
0
523
2696
2.76
59.64
2.4
2.4
2.76
2.86
mg/l
0.44
456
2291
106
191
6.02
57.16
4.2
2.0
95.87
86.67
%
3.70
106
186
48
30
16.67
56.66
3.0
1.4
562.85
426.96
e6/l
0.56
41
23
61
58
11.06
56.33
1.4
1.4
—
—
—
0
0
61
60
10.69
55.03
1.2
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
138
335
4.56
52.87
3.4
2.7
0.31
0.37
iu/ml
1.51
80
196
74
104
7.55
50.48
2.6
1.3
—
—
—
0
0
76
111
7.27
50.10
2.6
1.2
—
—
—
0
0
76
111
7.27
50.10
2.6
1.2
—
—
—
0
0
74
105
7.47
50.05
2.6
1.2
—
—
—
0
0
74
106
7.40
49.63
2.6
1.2
—
—
—
0
0
75
111
7.17
48.84
2.6
1.2
—
—
—
0
0
149
410
4.04
48.24
4.5
1.8
—
—
—
0
0
640
3932
2.46
46.99
4.2
3.0
315.46
137.48
ug/l
10.18
608
3598
206
717
3.29
46.75
2.4
1.7
—
—
—
0
0
169
520
3.65
46.52
2.2
1.4
3.97
2.83
ug/l
0.54
133
383
79
133
6.31
45.49
5.9
6.4
10.46
13.02
mg/l
4.50
72
127
179
602
3.35
42.74
5.5
3.5
0.91
2.07
mmol/l
3.14
128
436
197
707
3.17
42.22
5.8
3.7
4.68
5.20
kpa
12.74
184
670
808
5709
2.48
40.69
18.5
4.8
6.62
6.89
mmol/l
3.74
793
5442
268
1171
2.69
39.83
7.1
3.2
5.69
5.86
kpa
1.94
263
1137
262
1146
2.68
38.76
7.2
3.2
0.96
1.95
mmol/l
3.28
225
995
403
2171
2.34
37.82
7.8
3.7
86.14
82.99
%
1.66
395
2116
366
1892
2.39
37.77
2.6
1.6
1.41
1.48
mg/l
0.14
317
1498
125
384
3.54
34.14
2.9
1.7
—
—
—
0
0
585
3781
2.14
33.94
5.3
3.4
2084.46
1691.20
ng/l
1.40
547
3300
156
552
3.12
33.89
1.7
1.6
—
—
—
0
0
511
3151
2.14
33.35
4.4
3.4
43.86
97.86
e6/l
1.01
434
2430
57
98
6.07
32.05
1.2
1.2
223.43
190.25
miu/ml
0.18
15
31
694
4871
2.11
31.41
17.7
19.9
1.31
1.38
inr
2.76
601
4098
119
374
3.44
31.31
6.2
3.9
24.02
24.75
mmol/l
1.83
109
336
190
805
2.64
29.33
2.0
1.7
377.19
373.27
nmol/l
0.09
183
720
32
34
9.66
27.17
1.2
1.1
—
—
—
0
0
436
2689
2.02
26.94
4.6
3.3
0.56
0.51
e6/l
0.17
358
2002
529
3508
1.96
26.35
5.4
4.0
63.96
117.60
e6/l
2.10
436
2493
156
633
2.70
26.10
8.3
3.4
23.21
24.23
mmol/l
2.89
156
622
503
3299
1.95
25.69
2.2
1.7
18.45
19.96
nmol/l
1.54
476
2724
866
6850
2.15
25.54
36.7
5.7
76.49
78.56
u/l
0.64
855
6341
363
2131
2.04
25.46
1.9
1.8
1052.78
1157.62
nmol/l
1.24
309
1612
373
2247
1.99
24.08
3.2
2.6
6.35
5.10
e6/l
0.86
358
2033
42
73
5.94
23.34
1.6
1.5
—
—
—
0
0
30
11
27.97
22.33
1.3
1.0
—
—
—
0
0
272
1516
2.05
21.49
4.1
3.2
2.29
2.18
e6/l
0.10
139
764
77
233
3.47
21.39
1.5
1.4
—
—
—
0
0
77
233
3.47
21.39
1.5
1.4
—
—
—
0
0
212
3681
0.48
20.79
1.8
1.9
1.47
1.29
mmol/l
2.86
190
3045
287
1683
1.95
19.37
3.9
3.1
1.13
1.55
e6/l
0.80
157
940
73
229
3.34
19.16
2.8
2.6
1.98
1.83
mg/l
0.57
65
194
439
2962
1.79
18.89
2.8
2.3
60.68
61.55
u/l
0.06
420
2710
331
2058
1.86
18.57
6.8
2.3
2.49
2.45
mmol/l
3.30
306
1808
91
333
2.89
18.38
2.5
3.1
—
—
—
0
0
401
2684
1.77
17.40
6.2
2.6
33.84
37.23
u/l
0.36
384
2510
558
4099
1.72
17.34
3.7
2.3
—
—
—
0
0
524
3789
1.72
17.20
36.3
10.7
0.00
0.00
e9/l
2.37
440
3060
762
6110
1.77
17.16
6.6
5.1
18.29
3535.22
e6/l
2.23
14
101
63
195
3.36
16.89
1.8
1.9
13.79
39.38
u/ml
0.50
55
153
209
1151
2.00
16.67
6.9
6.7
95.41
94.86
%
0.67
199
1114
90
345
2.75
16.66
1.2
1.9
33.77
38.88
u/l
1.52
81
294
226
1282
1.96
16.54
7.1
6.5
0.69
1.02
mmol/l
0.42
175
1052
73
252
3.03
16.35
1.6
1.7
0.24
0.22
g/l
0.60
67
240
225
1284
1.94
16.15
7.5
6.6
4.88
5.07
kpa
1.41
213
1235
225
1284
1.94
16.15
7.5
6.6
11.71
11.27
kpa
0.77
214
1234
74
260
2.98
16.07
1.6
1.7
1.15
1.15
g/l
0.08
69
245
194
1054
2.02
16.03
7.9
7.2
105.22
120.60
g/l
20.72
186
1036
127
587
2.31
15.84
9.3
9.1
13.74
15.74
%
12.41
121
570
559
4175
1.67
15.80
5.8
4.4
43.66
96.00
ng/l
1.72
503
3304
30
55
5.58
15.78
1.4
1.3
—
—
—
0
0
326
2103
1.78
15.78
6.4
4.5
105.93
430.31
ng/l
5.38
290
1824
150
749
2.16
15.49
5.1
2.8
108.32
129.07
g/l
21.79
145
727
23
33
7.09
15.30
1.0
1.3
—
—
—
0
0
108
474
2.41
15.13
7.3
4.5
0.88
0.86
%
0.12
102
455
24
37
6.61
14.96
2.0
2.4
1054.08
1167.65
u/ml
0.10
24
37
26
44
6.03
14.83
1.5
1.4
—
—
—
0
0
809
6717
1.73
14.81
8.9
4.6
37.36
13.58
mm/h
65.56
777
6196
621
4827
1.64
14.53
2.9
2.3
87.41
94.29
pmol/l
3.62
461
2485
113
516
2.32
14.47
7.1
4.3
1.55
1.69
%
0.68
107
496
61
205
3.09
14.31
1.1
2.0
15.13
12.84
mg/l
0.87
55
187
120
568
2.25
14.11
5.1
2.8
24.56
25.30
mmol/l
1.31
115
547
27
50
5.51
14.05
1.4
1.4
—
—
—
0
0
27
27
10.22
14.00
1.9
3.3
3999.67
6624.00
u/ml
—
6
5
146
768
2.04
13.07
1.9
1.9
0.20
0.19
g/l
0.28
135
694
758
8670
0.61
12.41
4.9
6.6
2.45
2.51
mmol/l
1.07
703
7907
25
52
4.89
11.46
1.0
1.1
—
—
—
0
0
45
146
3.17
11.23
1.3
1.3
—
—
—
0
0
740
8408
0.65
10.12
4.4
5.5
1.34
1.44
mmol/l
9.31
686
7630
21
42
5.08
10.07
1.4
1.2
37.90
24.84
u/l
0.58
21
37
535
4242
1.50
9.93
2.9
2.4
82.80
79.68
nmol/l
1.67
503
3690
750
8474
0.65
9.63
4.5
5.6
4.28
4.41
mmol/l
2.42
700
7748
19
23
8.38
9.08
1.1
1.0
—
—
—
0
0
53
213
2.56
8.99
8.3
6.3
105.38
105.30
mmol/l
0.03
47
198
28
78
3.66
8.87
1.2
1.3
89.75
99.76
pmol/l
0.34
28
78
746
8399
0.67
8.86
6.4
7.6
40.34
40.78
mmol/mol
0.71
703
7755
21
47
4.53
8.86
1.4
1.1
125.86
96.83
u/l
0.34
21
41
591
4868
1.45
8.54
4.6
4.2
0.00
0.00
estimate
-0.00
118
991
161
1003
1.71
8.33
4.0
3.2
264.17
247.94
ng/l
0.16
148
928
16
17
9.53
8.29
1.4
1.4
—
—
—
0
0
59
263
2.31
8.03
4.5
3.8
3.16
1.67
index
0.58
37
127
125
732
1.80
8.02
6.4
6.2
23.83
24.47
mmol/l
0.85
116
706
598
4974
1.43
7.97
4.7
4.2
0.02
0.02
estimate
0.11
119
955
770
8560
0.68
7.81
6.0
5.8
6.13
6.13
mmol/l
0.03
712
7698
24
66
3.69
7.76
1.3
1.3
9.32
10.75
u/l
0.20
19
59
83
430
2.00
7.73
3.1
2.1
330.53
990.75
ug/l
0.76
78
404
129
776
1.75
7.55
2.7
2.2
42.13
41.06
u/l
0.05
108
620
20
50
4.05
7.36
1.1
1.1
—
—
—
0
0
51
222
2.36
7.34
1.3
2.3
28.47
34.01
umol/l
1.11
38
200
591
4951
1.41
7.31
4.6
4.2
12.69
0.00
estimate
0.50
128
1021
7
0
+∞
7.30
1.9
0.0
—
—
—
0
0
12
11
11.01
6.80
11.0
8.5
4.74
4.96
mmol/l
0.14
12
11
18
32
5.70
6.77
1.1
1.1
765.56
1610.19
miu/ml
2.06
18
32
37
144
2.62
6.75
1.4
1.5
28.22
27.22
g/l
0.15
32
125
18
45
4.05
6.64
1.1
1.3
—
—
—
0
0
54
255
2.17
6.45
1.5
1.4
246.31
299.43
ug/g
1.33
35
155
47
210
2.29
6.41
1.3
1.6
—
—
—
0
0
727
8078
0.72
6.35
4.4
4.7
1.33
1.27
mmol/l
1.87
666
7240
28
97
2.93
6.35
1.3
1.3
—
—
—
0
0
30
109
2.80
6.25
1.2
1.3
—
—
—
0
0
32
122
2.67
6.10
1.3
1.5
1170.64
1701.36
e6/l
0.62
22
87
10
8
12.60
6.09
1.1
1.3
—
—
—
0
0
78
434
1.86
5.93
4.8
2.9
4.42
4.36
pmol/l
0.20
73
378
11
14
7.92
5.35
1.7
1.2
—
—
—
0
0
23
79
2.95
5.32
1.0
1.3
—
166.00
—
0
15
24
85
2.86
5.27
1.1
1.2
1.22
2.37
u/ml
—
9
27
5
0
+∞
5.21
1.4
0.0
—
—
—
0
0
8
6
13.42
5.08
1.1
1.2
308.00
190.67
nmol/l
—
8
6
8
6
13.42
5.08
1.3
1.3
—
—
—
0
0
40
187
2.18
4.96
1.3
1.4
—
—
—
0
0
15
41
3.69
4.93
4.5
3.8
0.60
1.05
index
1.19
15
41
134
911
1.53
4.83
2.2
2.2
136.13
183.80
ug/g
1.18
111
723
8
7
11.50
4.79
1.1
1.0
—
—
—
0
0
15
42
3.61
4.77
1.1
1.0
—
—
—
0
0
49
253
1.98
4.70
1.3
1.5
0.12
0.11
iu/ml
0.03
11
58
50
266
1.92
4.42
4.1
2.2
112.14
130.70
g/l
6.85
43
216
23
88
2.65
4.41
1.1
1.2
2.63
10.32
u/ml
—
8
44
57
320
1.82
4.28
2.7
3.5
0.78
0.83
nmol/l
0.41
36
264
49
262
1.91
4.27
6.4
2.9
7.58
7.75
mmol/l
0.14
49
253
15
47
3.22
4.06
1.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
18
5.59
3.98
1.3
2.0
246.30
208.89
%
—
10
18
64
381
1.72
3.96
1.6
1.9
3.62
7.39
iu/ml
—
8
97
402
3412
1.28
3.68
2.4
2.3
149.55
242.72
u/l
2.58
386
3212
11
25
4.43
3.62
1.0
1.1
—
—
—
0
0
24
107
2.27
3.40
1.3
1.5
14036.90
93051.17
e6/l
—
10
59
15
54
2.80
3.26
1.3
1.7
16.32
15.16
umol/l
0.17
15
45
135
995
1.41
3.25
4.7
3.5
—
—
—
0
0
9
19
4.77
3.24
1.0
1.1
—
—
—
0
0
573
5151
1.23
2.97
3.8
3.1
65.14
50.59
u/l
1.76
552
4704
49
780
0.61
2.92
1.2
1.4
—
—
—
0
0
25
122
2.07
2.88
2.7
3.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
40
3.02
2.70
1.0
1.2
—
—
—
0
0
24
122
1.99
2.51
1.4
1.8
89.05
90.02
%
0.26
24
122
40
241
1.68
2.47
1.6
1.6
—
—
—
0
0
287
2444
1.23
2.40
4.4
3.7
0.01
0.01
estimate
0.13
99
768
328
3753
0.82
2.33
3.3
3.5
6.66
7.12
mmol/l
1.32
295
3149
9
29
3.12
2.23
1.4
1.3
—
—
—
0
0
5
9
5.57
2.21
1.0
1.7
—
—
—
0
0
31
183
1.71
2.09
1.2
1.3
—
—
—
0
0
39
245
1.61
2.09
1.2
1.1
—
—
—
0
0
768
8100
0.84
2.06
5.6
5.3
2.09
2.04
mu/l
0.46
731
7321
10
232
0.43
2.03
1.0
1.4
—
—
—
0
0
33
201
1.66
2.00
1.0
1.3
20.77
48.87
e6/l
0.44
22
161
24
134
1.81
1.96
6.3
5.9
6.05
7.75
mmol/l
3.05
19
115
33
203
1.64
1.94
1.1
1.4
14.68
799.39
e6/l
0.86
22
168
38
243
1.58
1.92
1.2
1.1
—
—
—
0
0
889
8515
1.21
1.86
71.3
16.8
22.00
26.45
mg/l
4.67
863
7072
13
59
2.22
1.84
1.1
1.0
297.62
284.28
mg/l
0.22
13
53
339
3796
0.85
1.80
3.8
4.2
24.87
7.80
mg/mmol
3.53
259
2396
7
23
3.06
1.80
1.0
1.1
—
—
—
0
0
75
559
1.37
1.78
4.2
3.6
1.02
1.02
ratio
0.23
68
522
42
281
1.51
1.76
1.6
1.6
18542.85
13641.67
e6/l
0.36
27
200
105
1319
0.78
1.72
13.1
7.3
—
—
—
0
0
11
48
2.30
1.71
1.0
1.1
—
—
—
0
0
18
97
1.87
1.66
1.1
1.1
—
—
—
0
0
7
25
2.81
1.65
1.0
1.1
—
—
—
0
0
14
261
0.53
1.59
1.1
1.4
—
—
—
0
0
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
203
1747
1.20
1.52
1.3
1.3
1.06
1.65
u/ml
0.53
16
470
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
891
9208
0.84
1.51
92.4
25.3
114.98
133.92
g/l
183.75
880
9044
891
9207
0.84
1.50
92.5
25.6
34.83
39.90
%
140.38
880
9036
891
9207
0.84
1.50
91.7
25.1
3.69
4.42
e12/l
190.12
872
8896
891
9207
0.84
1.50
92.0
25.1
189.53
239.33
e9/l
72.48
873
8936
891
9206
0.84
1.49
91.6
25.0
96.33
91.79
fl
100.89
881
9040
7
28
2.51
1.45
1.0
1.1
—
—
—
0
0
12
59
2.05
1.44
1.0
1.1
—
—
—
0
0
17
95
1.80
1.43
1.9
2.1
0.56
1.40
u/field
—
9
57
788
8210
0.87
1.42
56.4
16.5
65.78
71.95
ml/min/173m2
10.79
750
7617
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
5
121
0.41
1.38
2.2
1.4
—
—
—
0
0
41
290
1.43
1.36
1.4
1.3
—
—
—
0
0
106
866
1.25
1.33
1.3
1.3
—
—
—
0
0
44
321
1.39
1.25
1.2
1.2
—
—
—
0
0
15
85
1.78
1.23
1.0
1.1
—
—
—
0
0
10
49
2.05
1.22
1.1
1.3
—
—
—
0
0
10
49
2.05
1.22
3.8
4.4
—
—
—
0
0
313
2839
1.14
1.20
4.5
4.2
0.02
0.00
estimate
0.39
93
895
20
125
1.61
1.18
1.8
1.4
—
—
—
0
0
0
33
0.00
1.16
0.0
1.5
—
—
—
0
0
5
20
2.51
1.15
1.0
1.9
0.60
0.60
mmol/l
—
5
20
890
9151
0.87
1.13
80.6
22.6
109.77
83.67
umol/l
16.36
879
9008
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
33
234
1.42
1.12
1.6
1.6
—
—
—
0
0
396
3665
1.12
1.10
4.8
4.2
0.04
0.02
estimate
0.25
104
797
8
41
1.96
1.09
1.0
1.2
—
—
—
0
0
63
787
0.79
1.05
1.3
1.4
—
—
—
0
0
7
35
2.01
1.00
1.1
1.3
—
—
—
0
0
92
776
1.20
0.91
4.3
2.5
51.54
61.09
ml/min/173m2
1.94
56
323
6
29
2.07
0.89
1.2
1.1
—
14.89
—
0
12
68
558
1.23
0.88
2.2
2.3
11.91
15.42
nmol/l
2.54
59
500
19
128
1.49
0.86
1.7
2.7
23.43
20.05
mg/l
—
7
43
877
8982
0.89
0.84
46.8
11.0
25.36
24.83
u/l
0.32
865
8588
27
197
1.38
0.82
2.0
1.9
2.10
31.85
iu/l
0.54
12
83
11
65
1.70
0.82
2.3
2.7
—
—
—
0
0
59
713
0.82
0.78
1.3
1.7
1.41
1.62
%
2.07
49
591
124
1090
1.15
0.78
2.5
2.5
5.32
7.40
ug/l
0.69
105
943
887
9048
0.91
0.67
73.9
21.5
3.98
4.02
mmol/l
2.92
878
8832
11
70
1.58
0.65
1.1
1.1
—
—
—
0
0
886
9035
0.91
0.65
65.8
21.4
138.71
139.74
mmol/l
25.43
877
8829
8
51
1.57
0.60
2.8
2.3
—
—
—
0
0
693
6729
1.08
0.59
79.4
20.5
15.27
13.76
%
91.05
685
6603
29
228
1.28
0.58
4.3
3.5
27.96
27.80
mg/l
0.01
22
163
6
35
1.72
0.57
1.0
1.3
63.77
40.41
u/l
—
6
24
11
161
0.68
0.57
1.1
1.4
—
—
—
0
0
8
55
1.46
0.56
1.6
1.8
83.00
90.09
umol/l
—
8
55
249
2335
1.09
0.53
1.7
1.8
425.39
33987706.64
pmol/l
2.39
215
1886
12
83
1.45
0.52
1.1
1.5
—
288.46
—
0
13
6
40
1.50
0.51
1.2
1.3
—
—
—
0
0
9
136
0.66
0.51
1.6
1.2
0.84
13.85
nmol/l
—
9
129
393
3766
1.07
0.47
5.0
4.4
2.54
2.11
ug/l
1.33
342
3363
24
292
0.82
0.40
1.2
1.5
0.37
0.35
mg/l
—
9
124
5
37
1.35
0.37
1.0
2.1
16.38
17.52
nmol/l
—
5
29
5
37
1.35
0.37
1.4
3.0
12.61
9.84
kpa
—
5
37
5
37
1.35
0.37
1.4
3.0
5.23
4.90
kpa
—
5
37
133
1241
1.08
0.35
3.7
5.6
33.20
33.53
%
0.10
98
782
6
44
1.37
0.34
1.0
1.3
126.62
153.35
pmol/l
—
6
44
24
285
0.84
0.33
2.3
2.3
108.51
96.98
ug/min
0.09
18
171
10
74
1.35
0.32
1.2
1.7
84.22
100.90
ng/l
—
10
74
7
56
1.25
0.29
1.0
1.2
—
—
—
0
0
7
56
1.25
0.29
1.0
1.2
—
—
—
0
0
8
63
1.27
0.27
1.0
1.2
—
—
—
0
0
8
65
1.23
0.27
1.0
1.2
—
—
—
0
0
9
74
1.22
0.25
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
159
1524
1.05
0.21
1.3
1.3
27.03
38.68
iu/ml
0.44
46
463
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
0.15
—
0
14
138
1438
0.95
0.18
1.3
1.3
11.95
12.75
u/ml
0.04
31
503
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
9
80
1.13
0.15
1.0
1.2
—
—
—
0
0
16
142
1.13
0.12
1.2
1.1
—
5.17
—
0
6
209
2124
0.98
0.08
3.0
3.0
0.91
0.76
ug/l
1.01
155
1484
41
429
0.95
0.08
1.2
1.2
161.86
94.38
u/ml
0.45
14
166
233
2305
1.01
0.05
4.8
4.4
1.02
1.02
kg/l
0.38
184
1501
12
110
1.09
0.05
1.0
1.1
—
63.15
—
0
13
303
3053
0.99
0.04
3.9
4.1
22.69
24.52
%
1.08
159
1548
26
253
1.03
0.01
1.3
1.3
—
3.04
—
0
29
676
6751
1.00
0.01
4.5
4.1
15.00
15.14
pmol/l
0.74
637
6045
16
166
0.96
0.00
1.6
1.9
184.31
207.63
pmol/l
0.37
16
156
32
326
0.98
0.00
1.1
1.1
—
—
—
0
0
10
98
1.02
0.00
1.0
1.1
—
78.33
—
0
6
22
223
0.99
0.00
1.2
1.2
—
7.74
—
0
16
0
6
0.00
0.00
0.0
1.7
—
11.17
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
9.58
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
30.48
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
8
84
0.95
-0.00
1.1
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
6.10
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MULT_MYELOMA – Multiple myeloma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).